|
|
||||||||
Departments of 1Animal and Poultry Science, 2Biomedical Sciences, 3Human Health and Nutritional Sciences, and 4Pathobiology, University of Guelph, Guelph, Ontario, Canada
Submitted 27 November 2006 ; accepted in final form 20 June 2007
| ABSTRACT |
|---|
|
|
|---|
glucose uptake; muscle glycogen; GLUT4; acute exercise
Postexercise increases in insulin sensitivity are thought to facilitate rapid muscle glycogen synthesis after glycogen-depleting exercise (26, 37, 47, 48) and potentially enable the process of glycogen storage to allow supercompensation (i.e., contents higher than before exercise). In this context, it has been suggested that insulin action on glucose metabolism is unchanged after exercise in horses (23, 25), potentially accounting for the slow rate of postexercise muscle glycogen resynthesis (up to 48–72 h) observed in this species (8, 25). However, to date, there have been no measurements of insulin sensitivity following a single bout of exercise in horses. Therefore, the purpose of this study was to investigate the time course of insulin sensitivity, skeletal muscle glycogen and GLUT4 protein contents, and muscle GS activity after a single bout of glycogen-depleting exercise in horses. Given previous observations of slow postexercise muscle glycogen resynthesis (9, 17, 32, 35, 43), we predicted no change in insulin sensitivity during a 24-h period after a single bout of intense exercise.
| MATERIALS AND METHODS |
|---|
|
|
|---|
3 h daily during which time horses were fitted with muzzles to prevent grazing.
Experimental design.
A replicated 4 x 4 Latin square design was used to determine the effects of time after a single bout of exercise on dependent variables. A 120-min euglycemic-hyperinsulinemic clamp (EHC) was administered in the resting state [no exercise in the previous 48 h; control (Con)] and at 0.5, 4, or 24 h after an
1-h bout of exercise. The exercise was undertaken between 0700 and 0800. Therefore, the Con, 0.5-h, and 24-h EHCs were administered between
0800 and 1100, whereas the 4-h EHC was commenced between 1200 and 1300. In all experiments, feed was withheld starting at 1900 the day before the EHC. In the 0.5- and 4-h treatments, horses were denied access to feed during the period between the end of exercise and the start of the EHC. In the 24-h postexercise treatment, horses received
3 kg of hay at 12 h postexercise. For each horse, the order of trials was randomized, and there was a 10-day interval between trials.
Incremental exercise test.
Before the experiments, horses completed an incremental exercise test for measurement of the peak rate of oxygen consumption (
O2peak). With the treadmill set at a 3° incline, horses completed a 5-min warm up at 4 m/s, and then a loose-fitting face mask was applied for collection of respiratory gasses. Horses resumed trotting at 4 m/s for 90 s, after which the speed of the treadmill was increased by increments of 1 m/s every 60 s until horses reached fatigue. Fatigue was defined as the point at which the horse could no longer keep pace with the treadmill despite verbal encouragement. Oxygen consumption was measured continuously by use of an open-circuit indirect calorimeter (Oxymax-XL; Columbus Instruments, Columbus, OH), and the highest value recorded was designated as
O2peak. The oxygen and carbon dioxide analyzers were calibrated against gases of known composition before each experiment, and the overall accuracy of the system was verified by the nitrogen dilution technique. For each horse, linear regression analysis was used to determine the speeds corresponding to 50, 75, and 100% of
O2peak, and these speeds were used for the exercise protocol.
Exercise protocol.
Horses completed an exercise protocol on a treadmill set at a 3° incline. The exercise consisted of a 5-min warm up at 4 m/s, followed by 15 min at a speed that elicited 50%
O2peak, 20 min at 75%
O2peak, and four 1-min sprints at 100%
O2peak, each separated by a 5-min walk (1.6 m/s). This protocol was used because it could be accomplished by all horses in the trial and, without invoking a period of feed deprivation, would consistently deplete glycogen stores by
45–50% of the initial value, a quantity sufficient to stimulate glycogen repletion.
EHC. A 120-min EHC was conducted at the designated times after exercise or at rest. Either before exercise (0.5-h treatment) or 45 min before the EHC (all other treatments), catheters (14 gauge, 5.25 in.) were inserted into both jugular veins after aseptic preparation and desensitization of the overlying skin. One of these catheters was subsequently used for infusion of glucose and insulin and the other for collection of blood samples.
Initial blood samples were collected into tubes (Vacutainer, Fisher Health Care, Chicago, IL) containing either no additive (to harvest serum) or potassium EDTA (for plasma). After this collection, a priming dose of insulin (Humulin-R, Eli Lily, Indianapolis, IN) was given (18 mU/kg). Thereafter, insulin was infused at a constant rate of 3 µU·kg–1·min–1 using a peristaltic pump (Vet IV 2.2; Heska, Denver, CO). The insulin was diluted in isotonic saline, and homologous serum was added to the insulin infusate to prevent adsorption of insulin to plastic surfaces, thereby ensuring more accurate insulin delivery. Additional blood samples (3 ml) were drawn at 5-min intervals throughout the EHC for determination of glucose concentration by a precision glucometer (Acusoft, Roche Diagnostics, Laval, Quebec). A variable rate infusion (KD Scientific Precision Syringe Pump, Kansas City, MO) of glucose (50% wt/vol dextrose) was used to maintain blood glucose concentrations at 5 mM with the rate being adjusted if blood glucose concentration deviated by >0.2 mM from euglycemia. Blood samples (
17 ml) for subsequent determination of plasma glucose, lactate, and nonesterifed fatty acid (NEFA) and serum immunoreactive insulin and cortisol were obtained every 15 min. The samples were centrifuged at 1,500 g for 15 min, and the serum or plasma was stored at –20°C until analysis.
The first hour of the EHC was considered an equilibration period with data from the final 60 min used to determine the mean glucose infusion rate (GIR), which was taken as an index of insulin sensitivity (11, 38). Preliminary studies in three horses demonstrated that the insulin infusion protocol completely suppressed stable isotope-determined endogenous glucose production (EGP; means ± SD, preclamp = 6.7 ± 2.1 µmol·kg–1·min–1; 60–120 min of clamp = –1.3 ± 1.1 µmol·kg–1·min–1).
Muscle biopsy.
Five minutes before and at the end of the EHC (before termination of the insulin and glucose infusion), samples of middle gluteal muscle were taken by use of the needle biopsy technique (27). Specimens (
300–500 mg wet wt) were collected under aseptic conditions after desensitization of the area with 2% mepivacaine (Carbocaine, Deseret, Sandy, UT). The samples were collected at a uniform depth and site, alternating between the left and right middle gluteal muscles. Muscle samples were immediately flash frozen in liquid nitrogen and stored at –80°C until analysis of glycogen and GLUT4 protein content and GS activity.
Blood analyses. Serum immunoreactive insulin and cortisol were measured in duplicate by radioimmunoassay with commercial kits (Coat-a-Count, Diagnostic Products, Los Angeles, CA) validated for use in samples obtained from horses. Intra-assay coefficients of variation for insulin and cortisol were 7.3% and 6.1%, respectively. Plasma glucose and NEFA concentrations were measured (in triplicate) spectrophotometrically with a microplate reader and commercially available kits (glucose from Infinity Reagent, Thermo Electron, Waltham, MA; NEFA from WAKO Chemicals USA, Richmond, VA). Plasma lactate concentrations were measured in duplicate by use of an autoanalyzer (YSI 2300, Yellow Springs Instruments, Yellow Springs, OH). Intra-assay coefficients of variations for the glucose, NEFA, and lactate assays were, respectively, 3.9, 4.5, and 2.5%.
Muscle analyses.
A piece of each muscle sample was lyophilized and dissected free of visible blood, fat, and connective tissue. Aliquots of each sample (
20 mg dry wt) were powdered and subjected to acid hydrolysis before spectrophotometric measurement of glycogen content (as glucosyl units) as described previously (4).
Frozen wet muscle (
10 mg) was removed from each biopsy under liquid nitrogen for the determination of GS activity as previously described (34). Briefly, samples were homogenized in buffer (50 µl/1 mg) and centrifuged at 7,000 g at 4°C for 5 min, and aliquots of the supernatant (cytosolic fraction) were incubated for 45 min at 37°C for the determination of active (I form) and total GS (I + D forms) activity. The reaction was started with the addition of 8 mM UDP-glucose and stopped by heating at 90°C for 2.5 min. Samples were centrifuged, and the supernatant was removed for fluorometric assay of UDP. GS activity was calculated as nanomoles of UDP-glucose incorporated into glycogen per hour per milligram of protein. Muscle protein concentration of GS homogenates was measured with a bicinchoninic acid reagent kit (Pierce, Rockford, IL), and the ratio of the GS activities at 0 and 10 mM glucose-6-phosphate (G6P; I/I + D) was calculated.
Western immunoblotting for GLUT4.
Immunoblot analysis was performed to determined total GLUT4 content in muscle homogenates as previously described (24, 29). In brief, frozen muscle (30 mg) was homogenized on ice in protein lysis buffer, and equal amounts of protein (40 µg) were resolved on a 10% SDS-polyacrylamide gel before transfer to a nitrocellulose membrane (Hybond ECL, Amersham Biosciences, Buckinghamshire, UK). Membranes were incubated with a polyclonal antibody directed against rabbit GLUT4 (Biogenesis, Poole, UK) and subsequently an anti-rabbit horseradish peroxidase-linked antibody (Cell Signaling Technology, Beverly, MA). Protein bands were visualized with an enhanced chemiluminescence detection system (Alpha-Innotech FluorChem IS-9900, San Leandro, CA). GLUT4 protein was corrected to
-tubulin (Sigma-Aldrich, St. Louis, MO) protein bands imaged on the same membrane.
Statistical analyses. Descriptive statistics of continuous variables are expressed as means ± SD. Normality was tested using the Kolmogornov-Smirnov statistic. A two-way repeated-measures ANOVA was used to determine the effects of treatment and the time of the clamp on GIR, muscle glycogen, total GS, and GS activity ratio, and plasma lactate, NEFA, and cortisol and serum insulin concentrations. Data for GLUT4 protein content were analyzed by one-way repeated-measures ANOVA. Pearson correlation coefficients were calculated to determine the relationship between GS activity and muscle glycogen content and between muscle glycogen content and GIR. The null hypothesis was rejected at P < 0.05. Significant differences between means were identified by use of the Bonferroni t-test. A software program (Sigmastat 3.0, SSPS, Chicago, IL) was used for statistical analyses.
| RESULTS |
|---|
|
|
|---|
O2peak of the horses was 119.5 ± 17.8 ml·kg–1·min–1. Mean running speeds corresponding to 50, 75, and 100%
O2peak during the exercise trials were 6.2 ± 0.8, 8.7 ± 0.7, and 11.8 ± 0.9 m/s, respectively. One horse did not complete the 24-h treatment due to lameness. Accordingly, the data for the 24-h treatment represent the means ± SD for seven horses.
Blood glucose concentration before the start of the EHC was higher in the 0.5-h treatment (5.3 ± 0.7 mM) than in the other treatments (P < 0.001; 3.8 ± 0.3, 3.6 ± 0.4, 4.0 ± 0.1 mM for the Con and 4- and 24-h treatments, respectively). In all trials, a steady-state blood glucose concentration was reached after 40–55 min of the commencement of the EHC (Table 1). Serum insulin concentrations before and during the EHC were similar among the four trials, increasing significantly from resting values (<10 µU/ml) and reaching a plateau of
260–280 µU/ml after 45 min, which was sustained until the end of the EHC (Table 1). In each EHC, there was no effect of time during the clamp (60–90 min vs. 90–120 min) on mean GIR (Fig. 1). Over the final 60 min of each EHC, mean GIR at 0.5 h (6.7 ± 2.0 mg·kg–1·min)–1 was significantly (P < 0.05) lower than that shown for the other treatments (Con: 8.6 ± 2.7; 4 h: 9.0 ± 2.0; 24 h: 10.6 ± 2.2 mg·kg–1·min–1). Mean GIR at 4 and 24 h did not differ from GIR of Con.
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
This study utilized a 2-h EHC, a procedure that has been used in previous equine studies (42, 44). One limitation was the lack of measurement of EGP, with verification that the insulin infusion protocol suppressed EGP in each treatment condition. Nonetheless, in preliminary studies, the identical infusion protocol completely suppressed EGP, and it is therefore reasonable to assume that values for GIR during the final 60 min of the clamp were reflective of whole-body glucose disposal. We also had no measure of skeletal muscle glucose uptake, although, at least in rodents and humans, skeletal muscle (
50% of body mass in horses) is the major site of glucose disposal under conditions of insulin stimulation such as an EHC (11).
Consistent with our hypothesis, there was no increase in insulin sensitivity during a 24-h period following a single bout of exercise. In postexercise muscle samples, there was an increase in the ratio of active-to-total GS, resulting in an inverse relationship between the active GS and muscle glycogen content, a finding consistent with previous studies in horses, humans, and rats (17, 25, 31). However, this change was not accompanied by early postexercise increases in insulin sensitivity, nor was the GS activity ratio further increased by hyperinsulinemia in the early (0.5 and 4 h) postexercise period. Numerous factors have been proposed to influence the extent of any exercise-mediated enhancement of insulin sensitivity, including the duration and intensity of the exercise, the extent of muscle glycogen depletion, changes in the intrinsic activity and localization of GLUT4 transporters, and availability of exogenous glucose (6, 16, 22, 47). The duration and intensity of exercise completed in this study were in the range expected to evoke an increase in insulin sensitivity in other species. Despite the decrement in muscle glycogen content evident in samples from each postexercise treatment, insulin sensitivity in the horses did not increase during EHCs from 0.5 to 24 h postexercise, a time frame in which any contraction-mediated enhancement of insulin sensitivity would be expected to occur (12, 36).
Exercise-induced alterations in counterregulatory hormones such as cortisol, glucagon, and epinephrine and increases in NEFA could mask enhancement of insulin sensitivity shortly after exercise (2, 12, 13, 30, 33). In the present study, serum cortisol concentrations were higher than Con in the 0.5-h trial but were not different from Con in the 4- and 24-h trials. This elevation in serum cortisol evident 30 min after exercise may have contributed to the lower GIR noted in the 0.5-h postexercise treatment. Although exercise-induced changes in NEFA (45) and lactate concentrations (5) have been implicated in modulating changes in insulin sensitivity, no relationship between NEFA or lactate concentrations and insulin sensitivity was evident in this study.
Insulin and exercise/contractile activity are the most important physiological stimuli of glucose uptake and each can contribute to increases in GS activity in skeletal muscle. Both acute and chronic exercise have been demonstrated to enhance insulin-stimulated GS activity (1, 6, 20, 47, 48) although exercise-associated increases in the GS activity ratio noted in horses are less marked than observed in humans (3, 19, 47). Lacombe et al. (25) reported a GS activity ratio in resting horses similar to that noted in the nonexercise treatment in the present study, with a doubling of the ratio after strenuous exercise but no further increase in this ratio when a high-carbohydrate meal was consumed immediately after exercise. The absence of an insulin-induced increase in basal GS and the GS activity ratio at 0.5 and 4 h is consistent with the observations of these investigators. In our study, there was a prolonged time course (at least 24 h) of increased GS activity in the horses, and this sustained increase in the GS activity ratio at 24 h may reflect the lack of change in muscle glycogen content compared with that measured in the early postexercise treatments.
Insulin alone can stimulate GS by promoting its dephosphorylation via inhibition of glycogen synthase kinase-3 (GSK3) (
and
) after phosphorylation of this enzyme by Akt/protein kinase B at NH2-terminal serine residues (Ser21 in GSK3
and Ser9 in GSK3
). In humans, insulin stimulation has been shown to increase Akt phosphorylation and GS activity, following enhanced GSK3
deactivation/GS activation (1, 19, 20, 47). In the present study, GS activity increased after the EHC in the resting state (Con) or 24 h after exercise, a finding consistent with an insulin-induced increase in GS activity.
In human studies, increased GS activity has also been noted following exercise, with an associated increase in Akt phosphorylation and enhanced phosphorylation of GSK3
on inhibitory site Ser21 (39). An increase in the GS activity ratio was evident after all exercise treatments in the present study, but this activity ratio was not further enhanced by insulin stimulation in EHCs performed in the early (0.5 and 4 h) postexercise period. In a companion study using a similar protocol in horses (29), the authors of the present study observed that exercise resulted in increased Akt phosphorylation (at Ser473) and GSK3
phosphorylation (at Ser21) (but not GSK3
at Ser9) detectable at 30 min but not at subsequent time points following exercise, possibly reflecting a short timeframe for Akt phosphorylation/activation after muscle contraction (40, 41). Whereas hyperinsulinemia resulted in a further increment in Akt phosphorylation in each treatment, additional insulin-induced increases in GSK3
phosphorylation were only observed in the nonexercised and 24-h postexercise treatments (29), a finding consistent with unchanged GS activity ratio noted following the EHC at 0.5 and 4 h postexercise in the present study.
In the skeletal muscle samples obtained before each EHC, there was no detectable change in crude muscle membrane GLUT4 protein content. This observation is similar to that of Nout et al. (32) in which no changes in muscle GLUT4 protein or mRNA content were observed in horses after 60 min of moderate-intensity treadmill exercise, which lowered muscle glycogen content to
50% of its initial value. On the other hand, increases in GLUT4 protein (23) and mRNA content (18) were observed in middle gluteal skeletal muscle of horses after 3 consecutive days of intense exercise, which lowered muscle glycogen content by >70%. In this instance, the changes in muscle GLUT4 measured after the final day of exercise were likely the result of exercise training adaptations (14, 21). The absence of a postexercise increase in insulin sensitivity in the horses in this study would be consistent with little increase in the relative permeability of the cell membrane for glucose transport. The finding that equine skeletal muscle GLUT4 content is not enhanced after a single bout of exercise observed in this study and others (8, 15, 32, 35) would support this possibility. Further study is warranted to determine whether the rate and extent of GLUT4 translocation to the cell membrane can explain the unchanged insulin sensitivity and slow rate of postexercise glycogen resynthesis in this species.
In summary, the results of this study demonstrate that insulin sensitivity in horses is not increased by an acute bout of moderately intense exercise that results in a 50% reduction in muscle glycogen content. Exercise increased the GS activity ratio, and this ratio was not further increased by induced insulinemia at 0.5 and 4 h after exercise. Little change in muscle glycogen content up to 24 h following exercise was consistent with the lack of increase in insulin sensitivity during this period. These findings contribute to the understanding of the mechanism associated with the slow postexercise replenishment of muscle glycogen observed in horses compared with other species.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. P. Waller, G. J. F. Heigenhauser, R. J. Geor, L. L. Spriet, and M. I. Lindinger Fluid and electrolyte supplementation after prolonged moderate-intensity exercise enhances muscle glycogen resynthesis in Standardbred horses J Appl Physiol, January 1, 2009; 106(1): 91 - 100. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |